Tuesday, April 10, 2007
|
Patient Accrual for Oncology Trials
|
8:00 | Registration & Morning Coffee
8:30 | Symposium Begins
10:30 |Break
12:30-1:30 | Luncheon
3:00 | Break
4:30 | Workshop Concludes
4:45 | Reception & Opening of Exhibit Hall
It is estimated that out of 20% of adults who are eligible for oncology clinical trials, only 3-5% of adults diagnosed with cancer actually participate in them. This lack of patient participation adversely affects drug development timelines and prolongs trials. This workshop analyses the patient accrual issue and offers practical suggestions for how to mitigate the burden of enrolling patients in your clinical trial. Topics to be addressed include:
Using the Internet to Help Run a Clinical Study and Recruit Patients
This workshop will engage participants in a discussion about the current and future use of the Internet and Web-based applications for clinical trial patient recruitment and management. Topics will include:
The Patient's Perspective
The Physician's Perspective
Maintaining Momentum - How to Build a Community with those Working on Your Trial
Clinical Trial Design - Don't Shoot Yourself in the Foot
Q&A Session with the Workshop Leaders
Designed for Pharmaceutical, Biotech & CROs from Patient Recruitment Operations Trial Design
About the Workshop Leaders:
Michael Schuster, MD, Director of Clinical Trials, Division of Hematology/Oncology, NEW YORK PRESBYTERIAN HOSPITAL
Linda Wolf, Strategic Operations, BBK WORLDWIDE
Dalvir Gill, PhD, Executive Vice President, Clinical Research, PHARMANET
Nancy Davenport-Ennis, CEO, PATIENT ADVOCATE FOUNDATION AND NATIONAL PATIENT ADVOCATE FOUNDATION
Bill Kennedy, President, PK DATA
Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved